DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

Pfizer (NYSE: PFE)

28.28 0.35 (1.25%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PFE $28.28 1.25%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $28.12
Previous Close $27.93
Daily Range $28.00 - $28.52
52-Week Range $27.51 - $32.96
Market Cap $179.3B
P/E Ratio 17.57
Dividend (Yield) $1.04 (3.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 36,463,963
Average Daily Volume 26,644,558
Current FY EPS $2.26





Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website:

News & Commentary Rss Feed

MannKind Corporation's Investors Shouldn't Dance Around This Issue

It's not a good sign that MannKind's competitor can't IPO.

Roche’s Cancer Drug Sales Continue To Grow, May Face Competition In Medium Term

Amgen Sues Sanofi and Regeneron over PCSK9 Candidate - Analyst Blog

Can Valeant's Strong Q3 Entice Allergan?

Week Ahead Market Report: October 20, 2014

Why Pfizer (PFE) Stock Remains a 'Buy' at TheStreet

3 Stocks Reiterated As A Buy: PFE, MU, CELG

Guru Stocks at 52-Week Lows: GOOG, PFE, UN, E, MTU

Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?

The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?

How to Buy Stocks That Can Make Your Kids Rich

It takes a special kind of stock to produce decades of strong returns. Here's how to find them.

See More PFE News...

PFE's Top Competitors

PFE $28.28 (1.25%)
Current stock: PFE
JNJ $100.36 (1.17%)
Current stock: JNJ
ROG $55.28 (0.95%)
Current stock: ROG
GSK $43.63 (0.05%)
Current stock: GSK